About
Camereyes developed an AI-powered platform for early diagnosis and management of diabetic retinopathy, a leading cause of blindness. Their technology aimed to analyze retinal images to identify early signs of the disease, enabling timely intervention and preventing vision loss.
Technology stack
detected 2026-05-24Est. monthly stack spend~$60/mo
Emailnone
Hosting
AWS
AWSComments
No comments yet. Be the first to share your take.
Frequently asked
What does Camereyes do?
Camereyes developed an AI-powered platform for early diagnosis and management of diabetic retinopathy, a leading cause of blindness. Their technology aimed to analyze retinal images to identify early signs of the disease, enabling timely intervention and preventing vision loss.
How much funding has Camereyes raised?
Camereyes has raised a total of $11M in funding. The most recent round on record is Seed.
Where is Camereyes headquartered?
Camereyes is headquartered in Tel Aviv, Israel.
When was Camereyes founded?
Camereyes was founded in 2015.
What industry does Camereyes operate in?
Camereyes operates in Healthcare, Optometry, Diabetic Retinopathy, Retina, HealthTech, MedTech.
How many employees does Camereyes have?
Camereyes has approximately 1 people on record.
What is Camereyes's current status?
Camereyes's current operating status is: Inactive.